Cigna Corp vs Synopsys, Inc. — how do they compare? Cigna Corp trades at $302.59 (market cap $80.55B), while Synopsys, Inc. trades at $427 (market cap $83.07B). The key difference: Cigna Corp and Synopsys, Inc. are close in size by market cap, and Cigna Corp pays a 2.05% dividend while Synopsys, Inc. pays none. Which is the better fit depends on your goals.
| CI | SNPS | |
|---|---|---|
Market Cap | $80.55B | $83.07B |
Sector | Health | Technology |
52-Week High | $311.00 | $645.59 |
52-Week Low | $244.41 | $380.47 |
Enterprise Value | $103.65B | $91.43B |
Dividend Yield | 2.05% | — |
Trailing returns across standard periods
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →Synopsys is a provider of electronic design automation software, intellectual property, and software integrity products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. The firm's growing SI business allows customers to continuously manage and test the code base for security and quality. Synopsys' comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
Read more on SNPS →